Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Tags:
Pfizer, immuno-oncology, AstraZeneca, Bristol-Myers Squibb, Merck, Roche
AstraZeneca's plan to unite R&D hubs takes flight
Fierce Biotech
Tue, 02/17/15 - 12:47 pm
Tags:
AstraZeneca, R&D, UK, Sweden
AstraZeneca's patent on asthma drug invalidated by U.S. court
Yahoo/Reuters
Mon, 02/16/15 - 11:51 am
Tags:
AstraZeneca, asthma, Pulmicort, patents, generics, Actavis
AstraZeneca struggles to spin out anti-infectives division, coming down to the wire
Fierce Biotech
Mon, 02/16/15 - 10:16 am
Tags:
AstraZeneca, anti-infectives
AstraZeneca agrees to pay $7.9M to settle kickback allegations
Bizjournals.com
Wed, 02/11/15 - 05:38 pm
Tags:
AstraZeneca, whistleblower lawsuits, kickbacks, PBMs, Medco
Glaxo Tries To Turn A Triple Play
Seeking Alpha
Wed, 02/11/15 - 09:11 am
Tags:
GSK, COPD, Chiesi, AstraZeneca, Novartis, Biogen Idec
FDA puts off Mylan's Nexium generic, giving Teva's version free rein
Fierce Pharma
Tue, 02/10/15 - 10:47 am
Tags:
FDA, Mylan Labs, Nexium, generics, Teva Pharmaceuticals, AstraZeneca
AstraZeneca Might Need More Than Buzzwords To Bridge The Gap
Seeking Alpha
Tue, 02/10/15 - 08:50 am
Tags:
AstraZeneca, M&A
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
Tags:
patents, Big Pharma, Abilify, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Crestor, Eli Lilly, Gilead Sciences, GSK, Harvoni, Hospira, Merck, Novo Nordisk, Pfizer, Sovaldi, Tecfidera
AstraZeneca plc Beefs Up Precision Medicine Arsenal
Motley Fool
Mon, 02/9/15 - 08:20 am
Tags:
AstraZeneca, Novartis, Thermo Fisher, precision medicine
AstraZeneca embraces the biotech lifestyle in a make-or-break year
Fierce Biotech
Thu, 02/5/15 - 06:24 pm
Tags:
AstraZeneca, biotech
AstraZeneca reports loss; confirms purchase of Actavis unit
CNBC
Thu, 02/5/15 - 09:06 am
Tags:
AstraZeneca, Actavis, M&A, earnings, Tudorza Pressair, Daliresp
Moody's: Patent-cliff challenges will continue to dog big pharma
BioPharma Dive
Wed, 02/4/15 - 01:43 pm
Tags:
patents, patent cliff, Big Pharma, Pfizer, Eli Lilly, Merck, Amgen, Novo Nordisk, AstraZeneca, Bristol-Myers Squibb
AstraZeneca partner Ardelyx plunges after citing safety issue for lead drug
Fierce Biotech
Mon, 02/2/15 - 03:21 pm
Tags:
AstraZeneca, Ardelyx, tenapanor, IBS
AstraZeneca bets on 'genetic scissors' for range of new drugs
Yahoo/Reuters
Thu, 01/29/15 - 08:26 am
Tags:
AstraZeneca, R&D, CRISPR, genetic scissors
Pfizer's hunting for safe M&A bets, not high-risk pipeline deals
Fierce Biotech
Wed, 01/28/15 - 07:50 am
Tags:
Pfizer, M&A, Actavis, Teva Pharmaceutical, AstraZeneca, Merck KGaA
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
Motley Fool
Tue, 01/27/15 - 10:02 am
Tags:
Pfizer, M&A, AstraZeneca, Shire, AbbVie, Isis Pharmaceuticals
Teva's generic version of AstraZeneca's Nexium gets FDA approval
Marketwatch
Mon, 01/26/15 - 06:46 pm
Tags:
generics, Teva Pharmaceutical, AstraZeneca, Nexium, FDA
Insight - Big Pharma faces up to new price pressure from aggressive insurers
Yahoo/Reuters
Thu, 01/15/15 - 09:02 am
Tags:
insurance, Big Pharma, drug pricing, Express Scripts, AbbVie, Gilead Sciences, AstraZeneca, Eli Lilly
Stakes High for AstraZeneca Heart Drug Facing Tough Competition
Bloomberg
Thu, 01/15/15 - 08:50 am
Tags:
AstraZeneca, Brilanta

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.